National Institutes of Health
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing April 28, 2027.
Overview
The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and…